文献速递肝胆胰外科围术期管理与 ERAS

肾上腺皮质癌合并下腔静脉癌栓的切除与预后

Adrenocortical carcinoma with inferior vena cava tumor thrombus.
PubMed 文献 · Surgery · 2016-11-17

该回顾性研究纳入65例局部晚期非转移性肾上腺皮质癌患者,比较合并与不合并下腔静脉癌栓者的围手术期特征和生存。两组完全切除率、短期并发症及12个月总生存相似,但癌栓组24个月和60个月生存更差。结论认为尝试完全切除合理,但需谨慎选择患者。

要点

  • 合并下腔静脉癌栓的肾上腺皮质癌患者短期安全性与无癌栓者相似。
  • 癌栓组36个月后生存有限,需谨慎选择手术患者。

核心结论

  • 尝试完全切除肾上腺皮质癌合并下腔静脉癌栓似乎合理,因短期安全性和生存与无癌栓者相似。
  • 但合并癌栓患者36个月后生存有限,评估切除时应仔细选择患者。

研究设计与样本

  • 30年期间回顾性 review,纳入65例接受局部晚期(T4N0和T4N1)非转移性肾上腺皮质癌切除的患者。
  • 其中28例合并下腔静脉癌栓,37例无癌栓,比较围手术期特征、切除完整性、死亡率和生存。

主要发现

  • 两组完全切除率、辅助化疗和短期术后并发症发生率相似。

临床怎么用

  • 对于局部晚期非转移性肾上腺皮质癌合并下腔静脉癌栓,可考虑尝试完全切除,但需充分评估短期安全性和长期生存风险。
  • 术前应仔细选择患者,尤其是关注36个月后的生存限制。

局限性

  • 回顾性 review,样本量65例,可能受选择偏倚影响。
  • 30年期间数据,治疗模式和手术技术可能变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The safety, efficacy, and prognostic implications of resection of adrenocortical carcinoma with inferior vena cava tumor thrombus are poorly described. METHODS: A retrospective review was performed during a 30-year period on patients who underwent resection of locally advanced, nonmetastatic adrenocortical carcinoma. We compared patients with and without inferior vena cava tumor thrombus, examining perioperative characteristics, completeness of resection, mortality, and survival. RESULTS: We identified 65 patients who underwent resection of locally advanced (T4N0 and T4N1) adrenocortical carcinoma (28 patients with inferior vena cava tumor thrombus, 37 noninferior vena cava tumor thrombus). Rate of complete resection, adjuvant chemotherapy, and short-term postoperative morbidity was similar between groups. Overall survival was similar at 12-months. At 24 months overall survival was less in the inferior vena cava tumor thrombus group (59% vs 30%, P = .04). Differential survival through 60-month follow-up favored the noninferior vena cava tumor thrombus group (36% vs 0%, P = .001). Subgroup analysis including only patients with complete resection demonstrates similar survival at 24-months but at 36-months survival favored the noninferior vena cava tumor thrombus patients (65% vs 29%, P = .047) and this continued through 60 months (40% vs 0%, P = .049). CONCLUSION: Attempt at complete resection of adrenocortical carcinoma with inferior vena cava tumor thrombus seems justified particularly as short-term safety and survival are similar to patients without inferior vena cava tumor thrombus. However, survival beyond 36-months is limited in patients with inferior vena cava tumor thrombus. Patients being evaluated for resection in the setting of inferior vena cava tumor thrombus should be selected carefully.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Laan DV, Thiels CA, Glasgow A, et al. Adrenocortical carcinoma with inferior vena cava tumor thrombus. Surgery. 2016. PMID: 27866717. doi:10.1016/j.surg.2016.07.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。